Tableau 4.
Etiologies | Bactéries | Sensibilité |
---|---|---|
Perforation d'UGD | Escherichia coli (3/26) |
*** IPM, COL ** CRO, CIP, C |
Klebsiella pneumoniae (3/5) |
*** IPM, CTZ, COL, C ** TCC, CRO, CIP |
|
Staphylococcus aureus (1/3) | *** AMC, CRO, CTZ, C | |
Pseudomonas aeruginosa(1/3) | *** IPM, CTZ, COL | |
Enterobactersp (2/2) | *** CRO, COL, SXT, CIP | |
Aerobacter sp (2/2) | *** IPM, CIP | |
Morganella morganii (1/1) | *** CRO, CIP, C | |
Stenotrophomonas maltophilia (1) | *** IPM, CIP, SXT | |
Appendiculaire |
Escherichia coli (10/26) |
*** IPM, COL ** CRO, CIP, C |
Streptococcus sp (4/7) |
*** AMC, IPM, CRO, E ** AM, OX |
|
Klebsiella pneumoniae (1/5) |
*** IPM, CTZ, COL, C ** TCC, CRO, CIP |
|
Staphylococcus sp (2/4) | *** AMC, OX, CRO, CIP, GM | |
Streptococcus pneumoniae(1/2) |
*** AM, AMC, OX, TIC, TTC, IPM, CRO CTZ, E, C, SXT, FOX | |
Acinetobacter baumannii (1/1) | *** AMC, TCC, IPM, FOX, CRO, CTZ | |
Proteus mirabilis (1/1) | *** AMC, IPM, CRO, CTZ, GM, SXT | |
Perforation non traumatique du grêle (Typhique probable) |
Escherichia coli (6/26) |
*** IPM, COL ** CRO, CIP, C |
Staphylococcus sp (1/4) | *** AMC, OX, CRO, CIP, GM | |
Enterococcus sp (1/1) | *** IPM | |
Autres perforations |
Escherichia coli (3/26) |
*** IPM, COL ** CRO, CIP, C |
Streptococcus sp (2/7) |
*** IPM, AMC, CRO, E ** AM, OX |
|
Klebsiella pneumoniae (1/5) |
*** IPM, CTZ, COL, C ** TCC, CRO, CIP |
|
Staphylococcus aureus (2/3) | *** AMC, CRO, CTZ, C | |
Pseudomonas aeruginosa (2/3) | *** IMP, CTZ, COL |
Antibiotiques ayant un taux d'efficacité très satisfaisant (> 80%).
Antibiotiques ayant un taux d'efficacité satisfaisant (> 60%, ≤ 80%). Aminopénicillines (AM) ; Amoxicilline/acide clavulanique (AMC) ; Aztréonam (ATM) ; Céftriaxone (CRO) ; Céftazidime (CTZ) ; Ciprofloxacine (CIP) ; Colistine (COL) ; Gentamicine (GM) ; Chloramphénicol (C) ; Cotrimoxazole (SXT) ; Erythromycine (E) ; Tétracycline (TET) ; Céfoxitine (FOX) ; Ticarcilline (TIC) ; Ticarcilline/acide clavulanique (TCC) ; Imipenème (IPM).